
Advanced Infusion Therapies Delivered with Safety, Expertise, and Care.
Entyvio® (Vedolizumab) IV Infusion Therapy in Miami
Gut-Targeted Biologic Therapy for Crohn’s Disease and Ulcerative Colitis
Looking for Entyvio infusion therapy near you? Clearwell Infusion Centers offers safe, expert administration of Entyvio (vedolizumab) for patients with moderate to severe inflammatory bowel disease (IBD). As a leading infusion center in Miami, we provide private suites, flexible scheduling, and personalized, patient-centered care.
What Is Entyvio?
Entyvio® (vedolizumab) is an FDA-approved biologic therapy used to treat adults with moderate to severe ulcerative colitis or Crohn’s disease. It is a monoclonal antibody that specifically targets the gut’s immune system by blocking the α4β7 integrin, which plays a key role in chronic gastrointestinal inflammation.
Entyvio is administered by intravenous (IV) infusion, typically every 8 weeks after the initial loading doses.
Conditions Treated with Entyvio
Entyvio is indicated for adult patients with:
- Moderate to severe Ulcerative Colitis (UC)
- Moderate to severe Crohn’s Disease (CD)
Entyvio is generally prescribed when conventional treatments, such as corticosteroids or immunomodulators, have not provided sufficient symptom relief or remission.
Entyvio Side Effects
Entyvio is generally well tolerated, but as with all biologic therapies, side effects may occur.
Common side effects:
- Headache
- Nausea
- Joint pain
- Fatigue
- Fever
- Upper respiratory infections
- Infusion-related reactions (chills, rash, itching)
Serious infections are rare but possible. Patients are monitored during and after infusion for any adverse reactions.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Entyvio Website.
Why Choose Clearwell for Your Entyvio Infusion?
At Clearwell Infusion Centers in Miami, we provide a comfortable, efficient environment for Entyvio therapy. When you receive Entyvio IV treatment at Clearwell, you benefit from:
- Private treatment suites with spa-like amenities
- Low patient-to-nurse ratio for attentive care
- Flexible appointment times, including weekends and evenings
- Comprehensive insurance coordination, including prior authorizations and benefits checks
- ACHC-accredited facility and safety standards
- Close coordination with your prescribing provider and care team
Entyvio infusions typically take about 30 minutes and are administered every 8 weeks following the initial 0, 2, and 6-week induction doses.
Getting Started with Entyvio Treatment
If you’ve been diagnosed with Crohn’s disease or ulcerative colitis and prescribed Entyvio, Clearwell can help you get started quickly and confidently. We’ll coordinate with your gastroenterologist, confirm insurance coverage, and ensure your treatment experience is smooth and stress-free.
Questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.
Referring Providers: Partner with Clearwell Infusion Centers
Clearwell Infusion Centers works closely with gastroenterologists and IBD specialists to deliver safe, protocol-driven Entyvio therapy in an outpatient setting.
Why refer your patients to Clearwell?
- Fast turnaround for benefit verifications and prior authorizations
- Easy referral process and same-week scheduling
- Clinical documentation and follow-up sent to your office
- FDA-approved Cinryze administered by experienced infusion nurses
- ACHC-accredited and compliant with all safety protocols
To refer a patient for Entyvio therapy in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.
Interested in other therapies at Clearwell Infusion Centers?
Below is a partial list of our treatment options. If you want to get started, have questions about insurance, or don’t see your therapy listed, call us at 305-306-7147 for more information.
Actemra
Adakveo
Amvuttra
Avsola
Benlysta
Briumvi
Cimzia
Cinqair
Cinryze
Cosentyx
Entyvio
Evenity
Fasenra
Fabrazyme
Feraheme
Gammagard
Gamunex-C
Givlaari
HyQvia
InFed
Ilumya
Inflectra
Injectafer
IVIG
Keytruda
Kisunla
Krystexxa
Lemtrada
Leqembi
Leqvio
Monoferric
Nulojix
Ocrevus
Octagam

